Biotechnology company Amgen Inc. said Wednesday lower costs in its research and sales units boosted third-quarter profit by 24 percent, despite a continued downturn in anemia drug sales.

Most Watched: Karzai agrees to election run-off Labs Journalism Handbook Archive Site Index Video Index Thomson Reuters is the world's largest international multimedia news agency, providing investing news, world news, business news, technology news, headline news, small business news, news alerts, personal finance, stock market, and mutual funds ...

Eli Lilly & Co. said Wednesday it turned a profit in the third quarter as sales volume on several drugs climbed, but its newest drug and key source of future revenue started slowly.

Nurse Melody McKever administers a nasal spray dose of the H1N1/swine flu vaccine to Pediatrics Chairman Dr.

NEW YORK - Sanofi-Aventis is paying privately-held Wellstat Therapeutics Corp. up to $350 million under terms of a licensing deal for a potential diabetes drug, the companies said Wednesday.